Concepedia

Takafumi Sato

TS

Statistics

Publications

20

Citations

2.5K

H-Index

16

Active since

1986

Affiliations

Futaba (Japan)(Current)

Shionogi (Japan)

Hokkaido University

Toho University

Takafumi Sato is an author at Futaba (Japan) specializing in life sciences, antibiotic resistance, and infectious diseases.

ORCID

Publications per year

1986–2025

20

Publications

20

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text

, , +15

<i>In Vitro</i> Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

Akinobu Ito, Takafumi Sato, Merime Ota et al. · Antimicrobial Agents and Chemotherapy · 2017 · 378 citations · Full text

, , +17

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa

Akinobu Ito, Toru Nishikawa, Shuhei Matsumoto et al. · Antimicrobial Agents and Chemotherapy · 2016 · 333 citations · Full text

, , +15

<i>In Vitro</i> Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

Naoki Kohira, Joshua M. West, Akinobu Ito et al. · Antimicrobial Agents and Chemotherapy · 2015 · 241 citations · Full text

, , +13

Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases

Tsukasa Ito-Horiyama, Yoshikazu Ishii, Akinobu Ito et al. · Antimicrobial Agents and Chemotherapy · 2016 · 184 citations · Full text

, , +12

1–5 of 20